REVIEW OF MULTIMORBID CONDITIONS IN ATHEROSCLEROSIS
Keywords:
Keywords: atherosclerosis, osteoporosis, cardiovascular diseases, multimorbidity.Abstract
Annotation. A review of modern literature on the issues of multimorbidity of
atherosclerosis and osteoporosis is presented. There are quite a lot of various scientific
studies: experimental, clinical, epidemiological, which have confirmed the mutual
coherent relationship between these diseases. It was revealed, that they are based on
common risk factors and mechanisms of pathogenesis.
References
References.
Meldekhanov T. T. et al. Pathogenesis of atherosclerosis // Current
problems of theoretical and clinical medicine. – 2021. – T. 34. – No. 4. – pp. 21-28.
Don A., Nagai S., Sadykova D. Assessment of morphological changes in
the thyroid gland by test-point method with the introduction of dipsacoside // Astana
medical journal. – 2022. – No. S1. - P. 181-186. DOI 10.54500/2790-
S1.2022.181-186.
Haryanto T.I., Kurniawan A. Dyslipidemia is associated with severe
coronavirus disease 2019 (COVID-19) infection. Diabetes Metab Syndr.
;14(5):1463-5. doi: 10.1016/j.dsx.2020.07.054.
Don A., Shatmanov ST, Mamataliev AR, Kakharov ZA The study of morphometric aspects of the thyroid gland using the test-point method // Journal of
"New day in medicine". - No. 4 (42). - 2022. - S. 117 - 120.
Haverich A., Boyle EC Atherosclerosis pathogenesis and microvascular
dysfunction. – Springer International Publishing, 2019.
Boeva O. I., Khripunova A. A., Khripunova I. G. Lipid metabolism
disorders and atherosclerosis: diagnosis, possibilities of correction. – 2020.
Don AN, Reimnazarova GD, Nishanova AA Assessment of the
morphofunctional status of the thyroid gland upon administration of ladyginoside and
hederagenin // Journal of Medicine and Innovation. – 2021. - No. 4. - With. 8 – 13.
Don AN Morphofunctional state of the pituitary gland and thyroid gland
under the influence of ladyginoside and its aglycone hederagenin: dis. – Tashkent.
-20c, 1994.
Dukhin O. A. et al. The role of thrombin in the pathogenesis of
atherosclerosis and its complications // Cardiology. – 2022. – T. 62. – No. 3. – S. 73-
Don, A. N., & Nagai, S. G. (2022). Experimental study of the
administration of dipsacoside to the structure of the thyroid gland. Med Union, (1), 19-
Aronov D. M., Bubnova M. G., Drapkina O. M. Pathogenesis of
atherosclerosis through the prism of microvascular dysfunction // Cardiovascular
therapy and prevention. – 2021. – T. 20. – No. 7. – pp. 133-142.
2. Fadeev G. A. et al. Inflammatory mechanisms in the genesis of
atherosclerosis // Bulletin of modern clinical medicine. – 2020. – T. 13. – No. 6. – pp.
-67.
A. Don. Alteration – as a section of pathological anatomy [Text]:
Educational manual / A. Don. – Tashkent. - Publishing house “Complex Print”. – 2023.
– 136 p.
Global health assessments. WHO information bulletin dated 09.12.2020.
Don A. N., Mamadov Yu. M., Aleksandrov N. G. Hypolipidemic
properties of new triterpene glycosides // Current problems of human pathology:
Collection of scientific papers of the Tashkent State Medical Institute. Tashkent. –
– P. 52.
Obukhovich A. R., Ioskevich N. N. Osteoprotegerin as a marker of
atherosclerosis in type 2 diabetes mellitus (pathophysiological role of osteoprotegerin).
– 2022.
Dudinskaya E. N. et al. Relationship between bone mineral density and
parameters of preclinical atherosclerosis in middle-aged women // Osteoporosis and
Osteopathy. – 2020. – T. 23. – No. 4. – pp. 13-18.
Skripnikova I. A., Kolchina M. A., Meshkov A. N., Kiseleva A. V., Drapkina O. M. Arterial calcification, atherosclerosis and osteoporosis: only clinical
associations or a genetic platform? Cardiovascular therapy and prevention.
;20(7):3034. doi:10.15829/1728-8800-2021-3034.
Zhang Y, He B, Wang H, et al. Associations between bone mineral density
and coronary artery disease: a meta-analysis of cross-sectional studies. Arch
Osteoporos. 2020;15(1):24. doi:10.1007/ s11657-020-0691-1.
_ Muniyappa R, Tella SH. Osteoporosis and Cardiovascular Disease in
the Elderly. Conn's Handbook of Models for Human Aging, 2nd Edition.
;4(53):721-33. doi: 10.1016/B978-0-12-811353-0.00053-1.
Rodriguez A.J., Scott D., Hodge A., et al. Associations between hip bone
mineral density, aortic calcification and cardiac workload in community-dwelling
older Australians. Osteoporos Int. 2017;28(7):2239-45. doi:101007/s00198-017-4024-
Rajamannan N.M. Osteocardiology. Cardiac bone formation. London:
Springer; 2018. ISBN: 978-3-319-64994-8.
Skripnikova I. A., Kolchina M. A., Kosmatova O. V. et al. Assessment of
preclinical manifestations of atherosclerosis of the coronary and peripheral arteries and
parameters of bone strength in women. Rational Pharmacotherapy in Cardiology.
;16(6):868-75. doi:10.20996/1819-6446-2020-11-02.
Mishra B.H., Mishra P.P., Mononen N., et al. Lipidomic architecture
shared by subclinical markers of osteoporosis and atherosclerosis: The Cardiovascular
Risk in Young Finns Study. Bone. 2020; 131:115160. doi:
/j.bone.2019.115160.
Yuan J., Tickner J., Mullin B.H., et al. Advanced Genetic Approaches in
Discovery and Characterization of Genes Involved with Osteoporosis in Mouse and
Human. Front Genet. 2019; 10:288. doi:10.3389/fgene.2019.00288.
Hannan F.M., Newey P.J., Whyte M.P., et al. Genetics of skeletal
disorders. Handbook of Experimental pharmacology. 2020;262. ISBN: 978-3-030-
-5.
Yuan J., Tickner J., Mullin B.H., et al. Advanced Genetic Approaches in
Discovery and Characterization of Genes Involved with Osteoporosis in Mouse and
Human. Front Genet. 2019; 10:288. doi:10.3389/fgene.2019.00288.
Meshkov A., Ershova A., Kiseleva A., et al. The LDLR, APOB, and
PCSK9 Variants of Index Patients with Familial Hyper-cholesterolemia in Russia.
Genes (Basel). 2021;12(1):66. doi:10.3390/genes12010066.
Ergashova M. M., Tairova Z. K. Correlation relationship of bone mineral
density in patients with cardiovascular pathology in rheumatoid arthritis //
Volgamedscience. – 2021. – P. 194-196.
Skripnikova I.A., Kosmatova O.V., Kolchina M.A., Myagkova M.A., Alikhanova N.A. Atherosclerosis and osteoporosis. Common targets for cardiovascular
and anti-osteoporosis drugs (Part II). The effect of anti-osteoporosis drugs on the
condition of the vascular wall. Rational Pharmacotherapy in Cardiology 201 9;1
(3):359-367. DOI:1 0.20996/181 9-6446-2019-15-3-359-367.
Barbarash O. L. et al. Relationship between biochemical markers of bone
tissue metabolism, osteopenic syndrome and coronary atherosclerosis in men with
stable coronary heart disease // atherosclerosis. – 2022. – T. 11. – No. 2. – pp. 5-13.
Raskina T. A. et al. Assessment of the severity of coronary atherosclerosis
in men with coronary heart disease depending on bone mineral density // Osteoporosis
and Osteopathy. – 2020. – T. 23. – No. 2. – pp. 134-134.
Kokov A. N., Masenko V. L., Barbarash O. L. Prognostic significance of
the equivalent density of calcium deposits of the coronary arteries in men with
osteopenic syndrome who underwent coronary artery bypass grafting: a prospective
study // Therapeutic archive. – 2022. – T. 94. – No. 4. – pp. 467-472.
